Cargando…
Chimera Spectrum Diagnostics for Peptides Using Two-Dimensional Partial Covariance Mass Spectrometry
The rate of successful identification of peptide sequences by tandem mass spectrometry (MS/MS) is adversely affected by the common occurrence of co-isolation and co-fragmentation of two or more isobaric or isomeric parent ions. This results in so-called `chimera spectra’, which feature peaks of the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234510/ https://www.ncbi.nlm.nih.gov/pubmed/34207274 http://dx.doi.org/10.3390/molecules26123728 |
_version_ | 1783714100430241792 |
---|---|
author | Driver, Taran Bachhawat, Nikhil Frasinski, Leszek J. Marangos, Jonathan P. Averbukh, Vitali Edelson-Averbukh, Marina |
author_facet | Driver, Taran Bachhawat, Nikhil Frasinski, Leszek J. Marangos, Jonathan P. Averbukh, Vitali Edelson-Averbukh, Marina |
author_sort | Driver, Taran |
collection | PubMed |
description | The rate of successful identification of peptide sequences by tandem mass spectrometry (MS/MS) is adversely affected by the common occurrence of co-isolation and co-fragmentation of two or more isobaric or isomeric parent ions. This results in so-called `chimera spectra’, which feature peaks of the fragment ions from more than a single precursor ion. The totality of the fragment ion peaks in chimera spectra cannot be assigned to a single peptide sequence, which contradicts a fundamental assumption of the standard automated MS/MS spectra analysis tools, such as protein database search engines. This calls for a diagnostic method able to identify chimera spectra to single out the cases where this assumption is not valid. Here, we demonstrate that, within the recently developed two-dimensional partial covariance mass spectrometry (2D-PC-MS), it is possible to reliably identify chimera spectra directly from the two-dimensional fragment ion spectrum, irrespective of whether the co-isolated peptide ions are isobaric up to a finite mass accuracy or isomeric. We introduce ‘3-57 chimera tag’ technique for chimera spectrum diagnostics based on 2D-PC-MS and perform numerical simulations to examine its efficiency. We experimentally demonstrate the detection of a mixture of two isomeric parent ions, even under conditions when one isomeric peptide is at one five-hundredth of the molar concentration of the second isomer. |
format | Online Article Text |
id | pubmed-8234510 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82345102021-06-27 Chimera Spectrum Diagnostics for Peptides Using Two-Dimensional Partial Covariance Mass Spectrometry Driver, Taran Bachhawat, Nikhil Frasinski, Leszek J. Marangos, Jonathan P. Averbukh, Vitali Edelson-Averbukh, Marina Molecules Article The rate of successful identification of peptide sequences by tandem mass spectrometry (MS/MS) is adversely affected by the common occurrence of co-isolation and co-fragmentation of two or more isobaric or isomeric parent ions. This results in so-called `chimera spectra’, which feature peaks of the fragment ions from more than a single precursor ion. The totality of the fragment ion peaks in chimera spectra cannot be assigned to a single peptide sequence, which contradicts a fundamental assumption of the standard automated MS/MS spectra analysis tools, such as protein database search engines. This calls for a diagnostic method able to identify chimera spectra to single out the cases where this assumption is not valid. Here, we demonstrate that, within the recently developed two-dimensional partial covariance mass spectrometry (2D-PC-MS), it is possible to reliably identify chimera spectra directly from the two-dimensional fragment ion spectrum, irrespective of whether the co-isolated peptide ions are isobaric up to a finite mass accuracy or isomeric. We introduce ‘3-57 chimera tag’ technique for chimera spectrum diagnostics based on 2D-PC-MS and perform numerical simulations to examine its efficiency. We experimentally demonstrate the detection of a mixture of two isomeric parent ions, even under conditions when one isomeric peptide is at one five-hundredth of the molar concentration of the second isomer. MDPI 2021-06-18 /pmc/articles/PMC8234510/ /pubmed/34207274 http://dx.doi.org/10.3390/molecules26123728 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Driver, Taran Bachhawat, Nikhil Frasinski, Leszek J. Marangos, Jonathan P. Averbukh, Vitali Edelson-Averbukh, Marina Chimera Spectrum Diagnostics for Peptides Using Two-Dimensional Partial Covariance Mass Spectrometry |
title | Chimera Spectrum Diagnostics for Peptides Using Two-Dimensional Partial Covariance Mass Spectrometry |
title_full | Chimera Spectrum Diagnostics for Peptides Using Two-Dimensional Partial Covariance Mass Spectrometry |
title_fullStr | Chimera Spectrum Diagnostics for Peptides Using Two-Dimensional Partial Covariance Mass Spectrometry |
title_full_unstemmed | Chimera Spectrum Diagnostics for Peptides Using Two-Dimensional Partial Covariance Mass Spectrometry |
title_short | Chimera Spectrum Diagnostics for Peptides Using Two-Dimensional Partial Covariance Mass Spectrometry |
title_sort | chimera spectrum diagnostics for peptides using two-dimensional partial covariance mass spectrometry |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234510/ https://www.ncbi.nlm.nih.gov/pubmed/34207274 http://dx.doi.org/10.3390/molecules26123728 |
work_keys_str_mv | AT drivertaran chimeraspectrumdiagnosticsforpeptidesusingtwodimensionalpartialcovariancemassspectrometry AT bachhawatnikhil chimeraspectrumdiagnosticsforpeptidesusingtwodimensionalpartialcovariancemassspectrometry AT frasinskileszekj chimeraspectrumdiagnosticsforpeptidesusingtwodimensionalpartialcovariancemassspectrometry AT marangosjonathanp chimeraspectrumdiagnosticsforpeptidesusingtwodimensionalpartialcovariancemassspectrometry AT averbukhvitali chimeraspectrumdiagnosticsforpeptidesusingtwodimensionalpartialcovariancemassspectrometry AT edelsonaverbukhmarina chimeraspectrumdiagnosticsforpeptidesusingtwodimensionalpartialcovariancemassspectrometry |